PPTA's North America division is actively engaged in setting an advocacy and priority agenda for patient access. Staff monitors pending legislation, informs government representatives and works diligently to advance positions that protect the interests of patients who rely on life-saving, plasma protein therapies (PPTs). The Federal Affairs advocates with Members of Congress and Congressional staff on legislative issues related to PPTs, access to therapies and reimbursement. The Association also works in state capitals throughout the U.S. to ensure patient access to therapies, reimbursement and implementation of the Affordable Care Act (ACA).
In North America, PPTA advocates on behalf of patients not only at the state and federal level in the United States but also in Canada:
PPTA Proudly Supports World Hemophilia Day 2017 +
Register now for the 2017 Plasma Protein Forum! +
The 2017 Plasma Protein Forum will be held Tuesday, June 13 - Wednesday, June 14 at the Washington Marriott Georgetown in Washington, D.C.
Registration for the Forum includes access to all general sessions, the exhibit hall and all Forum breaks (you must be registered in order to participate in any of the Forum activities).Read More
The Hilfenhaus Award conferred to Prof. Farkas at the IPPC 2017 +
The 2017 Hilfenhaus Award was bestowed to Professor Henriette Farkas, MD, Ph.D., DSc, during IPPC 2017 for her work related to treating those suffering from Hereditary Angioedema (HAE) and working to improve treatments and patients’ quality of life. She is professor of allergology and clinical immunology at the Hungarian Angioedema Center at Semmelweis University in Budapest, Hungary.Read More